Cargando...
The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
Breast cancer tumors that demonstrate gene amplification or overexpression of human epidermal growth factor receptor 2 (HER2) are classified as HER2-positive. They account for approximately 15% of all breast cancers and represent an adverse prognostic factor. Over the past years, many new therapies...
Guardado en:
| Publicado en: | Breast Cancer (Dove Med Press) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445592/ https://ncbi.nlm.nih.gov/pubmed/26056489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S61579 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|